Migraine Epidemiology Forecast 2025-2034

A migraine refers to a severe headache that can cause pulsing head pain on one side of the head, typically lasting for 4 hours but can also persist for days. In the United States, around 12% of the population is affected by migraines, with most of the people experiencing 2 to 4 episodes in a month.

Migraine Epidemiology Forecast Report Coverage

The “Migraine Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of migraine. It projects the future incidence and prevalence rates of migraine across various populations. The study covers age, gender, and type as major determinants of the migraine-affected population. The report highlights patterns in the prevalence of migraine over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of migraine in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Migraine Disease Overview

Migraines cause throbbing, one-sided head pain that can interfere with the quality of life, affecting the person’s ability to meet personal and social obligations. The headache phase of a migraine persists typically for at least 4 hours but can also last for days. It is observed that a headache can get worse with bright lights, physical activity, strong odors, and loud noises. On average, most people are affected by 2 to 4 migraine attacks per month.

Migraine: Treatment Overview

Migraines can be managed with certain medications such as antiemetics, painkillers, and triptans. Non-invasive neuromodulation devices and home remedies (like essential oils and ginger) are some alternative treatment options. Nonsteroidal anti-inflammatory drugs (naproxen), beta-blockers, antidepressants, and calcium channel blockers are also recommended for relieving symptoms. Anticonvulsants are prescribed to raise levels of certain chemicals and reduce pain signals.

Epidemiology

The migraine epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for migraine by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for migraine and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• Migraines rank as one of the most common disorders worldwide, with estimates indicating that around 148 million people are affected by the condition.
• In the United States, women are approximately 3 times more likely to experience migraine attacks than men, with 17% of women having migraine every year compared to 6% of men.
• As per the American Migraine Foundation, in most cases, people experience a few migraine attacks in a month. However, about 2% of the population is affected by chronic migraine and are affected by the condition on more than 15 days in a month.
• According to the World Health Organisation, in 2021, headache disorders including migraines impact around 3.1 billion or 40% of the population.

Country-wise Migraine Epidemiology

The migraine epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of migraine varies between countries owing to differences in dietary patterns, genetic predisposition, stress levels, access to healthcare, and socioeconomic factors, among others. In the United States, it is estimated that more than 37 million individuals are affected by this neurological condition.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of migraine based on several factors.
• Migraine Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of migraine are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of migraine epidemiology in the 8 major markets?
• What will be the total number of patients with migraine across the 8 major markets during the forecast period?
• What was the country-wise prevalence of migraine in the 8 major markets in the historical period?
• Which country will have the highest number of migraine patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of migraine during the forecast period of 2025-2034?
• What are the currently available treatments for migraine?
• What are the disease risks, signs, symptoms, and unmet needs of migraine?

This product will be delivered within 3-5 business days.